Keyword: R&D

News

Toyota Boshoku and Mitsui in Plastics Alliance

20.04.2017 - Automotive component manufacturer Toyota Boshoku, part of the Toyota group, will partner with Mitsui Chemicals to commercialize a high impact-resistant plastic as a resin modifier...

News

Codexis in Protein R&D Pact with Tate & Lyle

11.04.2017 - US protein engineering company Codexis has signed a second multi-year supply agreement with multinational food ingredients company Tate & Lyle to supply a proprietary enzyme. The...

News

Astellas Pays €800 Million for Ogeda

07.04.2017 - Japan’s Astellas Pharma has agreed to buy privately held Belgian drug developer Ogeda in a transaction worth up to €800 million. The acquisition expands the Tokyo-headquartered...

News

Merck and Avillion in Psoriasis Pact

04.04.2017 - Germany’s Merck KGaA has entered a collaboration agreement with UK drug development company Avillion to develop its anti IL-17 A/F Nanobody as a treatment for plaque psoriasis, a...

News

DuPont Informs Ag Employees on Sell-offs

30.03.2017 - DuPont has begun talks with employees of agrochemicals facilities it plans to divest in exchange for EU approval of its $130 million merger with Dow Chemical. According to US...

News

GSK and Regeneron Back UK Biobank Project

29.03.2017 - UK drugmaker GlaxoSmithKline (GSK) and US biotech Regeneron Pharmaceuticals are investing in a gene sequencing project that uses anonymous patient data held by the UK Biobank. The...

News

EU Commission Greenlights DowDuPont

28.03.2017 - The European Commission (EC) on Mar. 27 approved the proposed $130 billion merger of Dow Chemical and DuPont into DowDuPont after the companies made promises to sell substantial...

News

MRC Licenses Hepatitis C Antibody to China

21.03.2017 - UK medical research charity MRC Technology has licensed an antibody to Newsummit Biopharma, a leading Chinese drug developer, in an effort to create a novel therapeutic for...